HCPCS Level II code Q1004 designates a new-technology intraocular lens in category 4, used to report advanced implantable lens devices for ophthalmic surgery. This code matters nationally as it standardizes reporting for novel intraocular lens technologies, enabling consistent billing and policy consideration across payers and care settings. Standardized codes like Q1004 support coverage reviews, pricing decisions, and tracking of new device adoption.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, typical sites of service, and the payers commonly involved in coverage decisions. The publication covers benchmarks and policy-relevant points such as how the code is positioned for new-technology lenses, implications for surgical billing in ambulatory surgical centers and hospital outpatient departments, and the role of HCPCS coding in payer evaluation of innovative ophthalmic devices.

The document also highlights areas where input data is not available and identifies topics for further review, including specific coverage policies, associated ICD-10 diagnoses, and related codes. This summary provides a national perspective for clinicians, administrators, and policy analysts seeking clarity on reporting and administrative handling of new intraocular lens technologies.